Clinical trial: five or ten cycles of granulocyte-monocyte apheresis show equivalent efficacy and safety in ulcerative colitis

Autor: Dignass, Au, Eriksson, A, Kilander, A, Pukitis, A, Rhodes, Jm, Dignass A, Vavricka S., Lochs, H, Porst, H, von Boyen, G, Raedler, A, Reinshagen, M, Bonaz, B, Vogel, W, Vavricka, S, Felley, C, Seibold, F, Ciacci, Carolina, Vecchi, M, Sablich, R, Malesci, A, Cottone, M, Riegler, G, Minoli, G, Lanzini, A, Hébuterne, X, Premchand, P, Douglas, K, Rhodes, J, Castro Larsa, L, Rodriguez Pérez, A, Lapidus, A, Makin, A, Vatn, Mh, Bouhnik, Y, Kruis, W, Bommelaer, G, Thillainayagam, A, Sturm, A, Baumgart, Dc, Annese, V, Indriolo, A, Emmrich, J.

Publikováno v: Alimentary Pharmacology and Therapeutics
Alimentary Pharmacology and Therapeutics, Wiley, 2010, 31 (12), pp.1286-95. ⟨10.1111/j.1365-2036.2010.04295.x⟩

APPENDIX: INVESTIGATORS BY PARTICIPATING SITE: A Dignass: Markus-Krankenhaus, Frankfurt, Germany; H Lochs: Campus Charité Mitte Berlin, Germany; H Porst: Städtisches Klinikum Dresden, Germany; G von Boyen: Universitäts-klinikum Ulm, Ulm, Germany;

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c3848348db2e70ce16581828a66593c4
https://pubmed.ncbi.nlm.nih.gov/20331579